BU applied for COBRE funding in the first round of applications in the Spring of 2000 (awarded in September of 2000). COBRE funding was used to establish an Administrative Core; the following three Research Cores: 1) Transgenic Mouse and Knockout Core (TMKC), Genomics and Bioinformatics Core (GBC), and Microscopy and Bioimaging Core (MBC); and five Research Projects (Events Regulating the Balance Between Resistance and Infection, Genetic Models of Human Dementias, Molecular Genetics of Ion Channels, Regulation of MAPK and NF-kB Activity and Downstream Signaling, and Mechanisms of Cellular Injury and Transformation). Each research project is directed by a senior Faculty Leader-Mentor, and comprised of three to five Sub-Projects headed by Junior Faculty Investigators. The Core Facilities are typically headed by a tenure-track Faculty Leader and directed on a day-to-day basis by a research-track Faculty Director. With the exception of some staffing to be completed in the near future, all Core Facilities have been fully implemented in the first one and a half years of the COBRE award. The supplemental funding application is being submitted for the purpose of purchasing additional large equipment items for the Core Facilities. Specifically, it is proposed to: 1) enhance the functionality of the TMKC by significantly upgrading an existing Histopathology Facility; 2) expand the operation of the GBC by incorporating the technology of expression profiling using spotted cDNA arrays; and 3) to upgrade the MBC through the acquisition of versatile light microscopy and digital electron microscopy capabilities. These upgrades are necessitated by the rapidly expanding use of the COBRE Core Facilities.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Exploratory Grants (P20)
Project #
3P20RR015578-03S1
Application #
6587768
Study Section
Scientific and Technical Review Board on Biomedical and Behavioral Research Facilities (STRB)
Program Officer
Arora, Krishan
Project Start
2000-09-30
Project End
2005-08-31
Budget Start
2002-09-01
Budget End
2003-08-31
Support Year
3
Fiscal Year
2002
Total Cost
$496,937
Indirect Cost
Name
Brown University
Department
Biochemistry
Type
Schools of Medicine
DUNS #
001785542
City
Providence
State
RI
Country
United States
Zip Code
02912
Lovasco, Lindsay A; Gustafson, Eric A; Seymour, Kimberly A et al. (2015) TAF4b is required for mouse spermatogonial stem cell development. Stem Cells 33:1267-76
Ribeiro, Jennifer R; Freiman, Richard N (2014) Estrogen signaling crosstalk: Implications for endocrine resistance in ovarian cancer. J Steroid Biochem Mol Biol 143:160-73
Casella, Cinzia; Miller, Daniel H; Lynch, Kerry et al. (2014) Oxysterols synergize with statins by inhibiting SREBP-2 in ovarian cancer cells. Gynecol Oncol 135:333-41
Grive, Kathryn J; Seymour, Kimberly A; Mehta, Rajvi et al. (2014) TAF4b promotes mouse primordial follicle assembly and oocyte survival. Dev Biol 392:42-51
Tomimaru, Yoshito; Xu, Chelsea Q; Nambotin, Sarah B et al. (2013) Loss of exon 4 in a human T-cell factor-4 isoform promotes hepatic tumourigenicity. Liver Int 33:1536-48
Minhas, Hassan M; Pescosolido, Matthew F; Schwede, Matthew et al. (2013) An unbalanced translocation involving loss of 10q26.2 and gain of 11q25 in a pedigree with autism spectrum disorder and cerebellar juvenile pilocytic astrocytoma. Am J Med Genet A 161A:787-91
De Cecco, Marco; Criscione, Steven W; Peckham, Edward J et al. (2013) Genomes of replicatively senescent cells undergo global epigenetic changes leading to gene silencing and activation of transposable elements. Aging Cell 12:247-56
Li, Hua; Jogl, Gerwald (2013) Crystal structure of decaprenylphosphoryl-?- D-ribose 2'-epimerase from Mycobacterium smegmatis. Proteins 81:538-43
Tomimaru, Yoshito; Koga, Hironori; Yano, Hirohisa et al. (2013) Upregulation of T-cell factor-4 isoform-responsive target genes in hepatocellular carcinoma. Liver Int 33:1100-12
Tomimaru, Yoshito; Koga, Hironori; Shin, Tai Ho et al. (2013) The SxxSS motif of T-cell factor-4 isoforms modulates Wnt/?-catenin signal activation in hepatocellular carcinoma cells. Cancer Lett 336:359-69

Showing the most recent 10 out of 152 publications